Self-Reported Neuropsychiatric Post–COVID-19 Condition and CSF Markers of Neuroinflammation
Shelli Farhadian, Hailey Reisert, Lindsay McAlpine, Jennifer Chiarella, Priya Kosana, Jennifer Yoon, Serena Spudich
Abstract
This case-control study assesses cerebrospinal fluid markers of neuroinflammation and blood-brain barrier disruption in individuals with post–COVID-19 condition who reported neuropsychiatric symptoms.
Topics & Concepts
NeuroinflammationCoronavirus disease 2019 (COVID-19)Cerebrospinal fluidMedicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Blood–brain barrierPathologyImmunologyInternal medicineCentral nervous systemInflammationDiseaseInfectious disease (medical specialty)OutbreakLong-Term Effects of COVID-19COVID-19 and Mental HealthTryptophan and brain disorders